Your browser doesn't support javascript.
loading
Systematic proteomics analysis revealed different expression of laminin interaction proteins in breast cancer: lower in luminal subtype and higher in claudin-low subtype.
Gao, Xiu-Li; Pan, Ting; Duan, Wen-Bo; Zhu, Wen-Bin; Liu, Li-Kun; Liu, Yun-Long; Yue, Li-Ling.
Affiliation
  • Gao XL; Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar, China.
  • Pan T; Department of Medical Technology, Qiqihar Medical University, Qiqihar, China.
  • Duan WB; Department of Medical Technology, Qiqihar Medical University, Qiqihar, China.
  • Zhu WB; Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar, China.
  • Liu LK; Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar, China.
  • Liu YL; Department of Thoracic Surgery, The Second Affiliated Hospital, Qiqihar Medical University, Qiqihar, China.
  • Yue LL; Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar, China.
Transl Cancer Res ; 13(5): 2108-2121, 2024 May 31.
Article in En | MEDLINE | ID: mdl-38881926
ABSTRACT

Background:

Breast cancer is a major public health concern. Proteomics enables identification of proteins with aberrant properties. Here, we identified proteins with abnormal expression levels in breast cancer tissues and systematically analyzed and validated the data to locate potential diagnostic and therapeutic targets.

Methods:

Protein expression level in breast cancer tissues and para-carcinoma tissues were detected by Isobaric Tags for Relative and Absolute Quantification (iTRAQ) technology and further screened through Gene Expression Profiling Interactive Analysis (GEPIA) database. Cellular components, protein domain and Reactome pathway analysis were performed to screen functional targets. Abnormal expression levels of functional targets were validated by Oncomine database, quantitative real time polymerase chain reaction (qRT-PCR) and proteomics detection. Protein correlation analysis was performed to explain the abnormal expression levels of potential targets in breast cancer.

Results:

Overall, 207 and 207 proteins were up- and down-regulated, respectively, in breast cancer tissues, and approximately 50% were also detected in the GEPIA database. The overlapping proteins were mainly extracellular proteins containing epidermal growth factor-like domain in leukocyte adhesion molecule (EGF-Lam) domain and enriched in laminin interaction pathway. Moreover, the downregulated laminin interaction proteins could be functional targets, which were also validated through Oncomine-Richardson and Oncomine-Curtis database. However, the lower expression level of laminin interaction proteins only fit for luminal breast cancer cells with no or low metastasis ability because the proteins achieved higher expression level in more invasive claudin-low breast cancer cells. In addition, when compared with corresponding in situ carcinoma tissues, above-mentioned proteins also showed higher expression levels in invasive carcinoma tissues. Finally, we have revealed the negative correlation between the laminin interaction proteins and the claudins.

Conclusions:

The laminin interaction protein, especially for laminins with ß1 and γ1 subunits and their integrin receptors with α1 and α6 subunits, showed lower expression levels in luminal breast cancer with no or lower metastatic ability, but showed higher expression levels in claudin-low breast cancer with higher metastatic ability; and their higher expression could be related to the low claudin expression.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Cancer Res Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Transl Cancer Res Year: 2024 Document type: Article Affiliation country: